G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.45 SEK -3.47%
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Gross Profit
kr81.8m
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Gross Profit
kr3.7B
CAGR 3-Years
26%
CAGR 5-Years
33%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Gross Profit
kr1.2B
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Gross Profit
kr1.3B
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
18%
MedCap AB (publ)
STO:MCAP
Gross Profit
kr834.2m
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
12%
M
Magle Chemoswed Holding AB
STO:MAGLE
Gross Profit
kr153.9m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Genovis AB
Glance View

Market Cap
1.7B SEK
Industry
Life Sciences Tools & Services

Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

GENO Intrinsic Value
25.55 SEK
Overvaluation 3%
Intrinsic Value
Price
G

See Also

What is Genovis AB's Gross Profit?
Gross Profit
81.8m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Gross Profit amounts to 81.8m SEK.

What is Genovis AB's Gross Profit growth rate?
Gross Profit CAGR 5Y
16%

Over the last year, the Gross Profit growth was -22%. The average annual Gross Profit growth rates for Genovis AB have been 15% over the past three years , 16% over the past five years .

Back to Top